Huawei to end production of leading edge mobile chipsets
By David Manners, Electronics Weekly (August 10, 2020)
Huawei is to end production of its top-of-the- range Kirin mobile processors in September, according to Caixin Global, the Chinese state news site.
“From Sept. 15 onward, our flagship Kirin processors cannot be produced,” Richard Yu (pictured) CEO of Huawei’s consumer unit said at the recent Mate 40 launch, “our AI-powered chips also cannot be processed. This is a huge loss for us.”
The US has barred any fab which uses US manufacturing equipment from making chips for Huawei’s chip subsidiary HiSilicon.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- X-Silicon Introduces the World's First Vulkan Driver Implementation for RISC-V, Enabling an entire Ecosystem of 3D Graphics, AI and Compute for Low-Power, Mobile, Edge and IOT Devices
- Synopsys and Samsung Electronics Collaborate to Achieve First Production Tapeout of Flagship Mobile CPU with Leading Performance on Samsung Foundry's GAA Process
- First Generation SiMa.ai Edge AI Platform Enters Mass Production Amidst Surge in Company Momentum
- Flex Logix Announces Production Availability of InferX X1M Boards for Edge AI Vision Systems
- Flex Logix Announces Production Availability Of InferX X1 PCIe Boards for Edge AI Systems
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design